Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
| Total | Transactions | Amount |
| Buys | 0 | $0 |
| Sells | 11 | $8,850,256 |
| Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
| 02 Feb 2024 17:25 | ARWR | ARROWHEAD PHARMACEUTICALS Inc | ANZALONE CHRISTOPHER RICHARD | Chief Executive Officer | 31 Jan 2024 | Sale | 19,730 | 32.71 | 645,368 | D |
| 02 Feb 2024 17:25 | ARWR | ARROWHEAD PHARMACEUTICALS Inc | ANZALONE CHRISTOPHER RICHARD | Chief Executive Officer | 31 Jan 2024 | Sale | 37,769 | 32.16 | 1,214,651 | D |
| 04 Jan 2024 17:25 | ARWR | ARROWHEAD PHARMACEUTICALS Inc | ANZALONE CHRISTOPHER RICHARD | Chief Executive Officer | 02 Jan 2024 | Sale | 5,318 | 31.25 | 166,188 | D |
| 04 Jan 2024 17:25 | ARWR | ARROWHEAD PHARMACEUTICALS Inc | ANZALONE CHRISTOPHER RICHARD | Chief Executive Officer | 02 Jan 2024 | Sale | 4,634 | 30.74 | 142,449 | D |
| 22 Dec 2023 17:04 | ARWR | ARROWHEAD PHARMACEUTICALS Inc | ANZALONE CHRISTOPHER RICHARD | Chief Executive Officer | 20 Dec 2023 | Sale | 12,000 | 28.54 | 342,480 | D |
| 27 Oct 2023 18:23 | ARWR | ARROWHEAD PHARMACEUTICALS Inc | ANZALONE CHRISTOPHER RICHARD | Chief Executive Officer | 25 Oct 2023 | Sale | 24,338 | 24.21 | 589,223 | D |
| 20 Sep 2023 18:10 | ARWR | ARROWHEAD PHARMACEUTICALS Inc | ANZALONE CHRISTOPHER RICHARD | Chief Executive Officer | 18 Sep 2023 | Sale | 26,232 | 28.27 | 741,579 | D |
| 20 Sep 2023 18:10 | ARWR | ARROWHEAD PHARMACEUTICALS Inc | ANZALONE CHRISTOPHER RICHARD | Chief Executive Officer | 18 Sep 2023 | Sale | 31,523 | 28 | 882,644 | D |
| 05 May 2023 19:04 | ARWR | ARROWHEAD PHARMACEUTICALS Inc | ANZALONE CHRISTOPHER RICHARD | Chief Executive Officer | 04 May 2023 | Sale | 25,992 | 40.02 | 1,040,200 | D |
| 05 May 2023 19:04 | ARWR | ARROWHEAD PHARMACEUTICALS Inc | ANZALONE CHRISTOPHER RICHARD | Chief Executive Officer | 04 May 2023 | Sale | 24,008 | 38.97 | 935,592 | D |
| 05 May 2023 19:04 | ARWR | ARROWHEAD PHARMACEUTICALS Inc | ANZALONE CHRISTOPHER RICHARD | Chief Executive Officer | 03 May 2023 | Sale | 54,928 | 39.14 | 2,149,882 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)